Sanofi to establish new API company in Europe
French pharmaceutical developer Sanofi announced on February 24 that it plans to expand operations by establishing a new independent company to target the active pharmaceutical ingredient (API) market in Europe. Read More
FDA enhances Purple Book with biosimilars upgrade
The U.S. Food and Drug Administration (FDA) will be upgrading the Purple Book, a database of FDA-licensed biological products, beginning on February 24. Early-phase upgrades will include full search functionality for all biosimilar products and their reference products. Read More
Florida CRO expands drug screening and manufacturing
Florida-based contract research organization (CRO) Alchem Laboratories is constructing a new building to grow its screening and chemical trail manufacturing capabilities. Read More
Audentes plans gene therapy facility in NC
Audentes Therapeutics has announced that it plans to invest $109 million to build a new 135,00-sq-ft gene therapy manufacturing facility in Sanford, NC, that is expected to be operational by 2021. Read More
MilliporeSigma to make Elypta liquid biopsy kits
MilliporeSigma has signed an agreement with Swedish molecular diagnostics company Elypta to be the contract manufacturer for Elypta's clinical diagnostic liquid biopsy kits. Read More
Thermo Fisher, NanoPin partner on infectious disease tech
Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry. Read More
Bioprocessing Summit Europe to be held March 24-26
The Bioprocessing Summit Europe will return to Barcelona, Spain, this year to address the growing global market for gene therapy and biopharmaceutical manufacturing. The summit will take place from March 24 to 26. Read More
Catalent completes acquisition of MaSTherCell
Catalent announced on February 11 that it has completed its acquisition of MaSTherCell Global, improving Catalent's position in the field of advanced biotherapeutics. Read More
GenapSys launches sequencer in Asia, lands new funding
GenapSys has launched its gene sequencer in the Asia-Pacific region and garnered $75 million in financing to support its international expansion. Read More
Arbor offers NGS coronavirus panel to researchers for free
Arbor Biosciences announced on February 12 that it will release its myBaits Expert hybridization-based panel for detecting infection with the 2019 novel coronavirus (2019-nCoV). The next-generation sequencing (NGS) panel will be offered free of charge to global researchers helping to identify the source organism and evolution of the virus. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter